Search hospitals > Nevada > Las Vegas
University Medical Center of Southern Nevada
Claim this profileLas Vegas, Nevada 89102
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Leukemia
Conducts research for Lung Cancer
361 reported clinical trials
3 medical researchers
Summary
University Medical Center of Southern Nevada is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Cancer, Breast Cancer, Tumors, Leukemia, Lung Cancer and other specialties. University Medical Center of Southern Nevada is involved with conducting 361 clinical trials across 543 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Chowdhury Ahsan, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
147 reported clinical trials
225 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Tumors
Expert in Leukemia
52 reported clinical trials
109 drugs studied
Chowdhury Ahsan, MDUniversity of Medical Center of Southern Nevada4 years of reported clinical research
Studies Heart Failure
Studies Coronavirus
3 reported clinical trials
7 drugs studied
Clinical Trials running at University Medical Center of Southern Nevada
Breast Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Bladder Carcinoma
Osteosarcoma
Gastric Cancer
Germ Cell Tumors
Renal Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University Medical Center of Southern Nevada?
University Medical Center of Southern Nevada is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Cancer, Breast Cancer, Tumors, Leukemia, Lung Cancer and other specialties. University Medical Center of Southern Nevada is involved with conducting 361 clinical trials across 543 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Chowdhury Ahsan, MD.
Where is University Medical Center of Southern Nevada located?
The University Medical Center of Southern Nevada is situated at 1800 W Charleston Blvd, Las Vegas, NV. For access, from I-15 South, exit at West Charleston Blvd and proceed west; the hospital is located on the right.
Who should I call to ask about financial aid or insurance network?
For financial assistance at University Medical Center of Southern Nevada, contact the Financial Arrangements Office at 806.775.9045 or 1.866.888.3267 for eligibility and application assistance for programs like the Lubbock County Medical Indigent Program. The Resource Assistance Department is also available at 806.775.9014 or 1.800.383.8039 for inpatient financial assistance eligibility. For insurance inquiries, call 702-383-2000.
What insurance does University Medical Center of Southern Nevada accept?
The University Medical Center of Southern Nevada accepts a variety of insurance plans, including most commercial plans for primary and specialty clinics (excluding myGeneration Senior Clinics) and Medicaid plans through Health Plan of Nevada, a UnitedHealthcare Company. Their Medicaid coverage includes comprehensive healthcare services like unlimited primary care visits, mental health appointments, and substance use treatment. Additionally, employees have access to two health plan options: Clark County Self-Funded (PPO) and Exclusive Provider Organization (EPO).
What awards or recognition has University Medical Center of Southern Nevada received?
University Medical Center of Southern Nevada (UMC) is recognized as the region's Metropolitan Anchor Hospital and Nevada's only hospital with a Level 1 trauma center and transplant center. UMC boasts a robust ambulatory division with 15 clinics across the valley and a partnership with the University of Nevada, Las Vegas (UNLV) Medical School, establishing it as a leading academic medical center. Despite financial challenges, UMC reinvests profits into facility improvements, human capital, and community outreach.